Related Experiment Videos

[Methods of detection of mutation in human cancers]

¹Centre des maladies du sein et service d'oncologie médicale, hôpital Saint-Louis, Paris.

Bulletin Du Cancer

|December 28, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer.

ESMO real world data and digital oncology·2026

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

ESMO open·2026

Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort.

ESMO open·2024

Silent brain infarct in migraine: Systematic review and meta-analysis.

Revue neurologique·2023

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.

Cancer medicine·2023

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.

Oncogene·2023

See all related articles